Accuray Acquires Linear Acceleration Technology
By MedImaging staff writers Posted on 30 Jan 2005 |
Accuray, Inc. (Sunnyvale, CA, USA), a manufacturer of image-guided full-body radiosurgical technology, has purchased specific assets of the High Energy Systems Division (HES) of American Science and Engineering, Inc. (AS&E; Billerica, MA, USA).
This transaction gives Accuray exclusive rights to manufacture, market, and sell x-band linear accelerators of medical applications. As such, Accuray now has full control over the technology and production of the x-band linear accelerator systems used in its CyberKnife stereotactic radiosurgery system. X-band linear accelerators are a subsystem of the Cyberknife and are used to produce the radiation beam that destroys cancer cells.
The Cyberknife is a noninvasive, 100% frameless image-guided radiosurgery system that ablates tumors and other lesions anywhere in the body without invasive surgery. The system treats in single or staged sessions, and monitors internal reference points in the anatomy to correct for patient movement in real time during actual treatment. It delivers multiple beams of precisely directed radiation that converge upon the tumor while minimizing damage to surrounding healthy tissue.
"With this transaction, Accuray gains increased control over its supply chain and enters in a new phase of growth. Bringing this production capability in-house will lower our cost of doing business and allows us to optimize product performance,” said Chris Raanes, COO of Accuray.
Related Links:
Accuray
American Science and Engineering
This transaction gives Accuray exclusive rights to manufacture, market, and sell x-band linear accelerators of medical applications. As such, Accuray now has full control over the technology and production of the x-band linear accelerator systems used in its CyberKnife stereotactic radiosurgery system. X-band linear accelerators are a subsystem of the Cyberknife and are used to produce the radiation beam that destroys cancer cells.
The Cyberknife is a noninvasive, 100% frameless image-guided radiosurgery system that ablates tumors and other lesions anywhere in the body without invasive surgery. The system treats in single or staged sessions, and monitors internal reference points in the anatomy to correct for patient movement in real time during actual treatment. It delivers multiple beams of precisely directed radiation that converge upon the tumor while minimizing damage to surrounding healthy tissue.
"With this transaction, Accuray gains increased control over its supply chain and enters in a new phase of growth. Bringing this production capability in-house will lower our cost of doing business and allows us to optimize product performance,” said Chris Raanes, COO of Accuray.
Related Links:
Accuray
American Science and Engineering
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans
A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable
Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read moreUltrasound
view channel
New Incision-Free Technique Halts Growth of Debilitating Brain Lesions
Cerebral cavernous malformations (CCMs), also known as cavernomas, are abnormal clusters of blood vessels that can grow in the brain, spinal cord, or other parts of the body. While most cases remain asymptomatic,... Read more.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read moreNuclear Medicine
view channel
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read more
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read moreGeneral/Advanced Imaging
view channel
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more